Načítá se...
Predictors of Higher Bone Mineral Density Loss and Use of Depot Medroxyprogesterone Acetate
OBJECTIVE: To identify possible predictive factors of higher bone loss, defined as at least 5%, at the spine or femoral neck, over time in depot medroxyprogesterone (DMPA) users. METHODS: Bone mineral density (BMD) was measured at the lumbar spine and femoral neck every 6 months in 240 white, black,...
Uloženo v:
| Hlavní autoři: | , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2010
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2811404/ https://ncbi.nlm.nih.gov/pubmed/20027031 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/AOG.0b013e3181c4e864 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|